CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 240 enrolled
Drug / intervention
Comprehensive Geriatric Assessmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04538157
NCT04538157N/ACompleted

Comprehensive Geriatric Assessment for Frail Older People With Chronic Kidney Disease to Increase Attainment of Patient-Identified Goals - A Cluster Randomised Controlled Trial - The GOAL Trial

The University of Queensland·interventional·Posted Sep 3, 2020·Updated Dec 5, 2024

In Brief

A clinical study evaluating Comprehensive Geriatric Assessment for Frailty and Chronic Kidney Diseases. Completed, enrolled 240 participants across 15 sites.

Detailed Summary

The GOAL trial addresses patient-prioritised research topics and outcomes and will be conducted, disseminated and implemented in partnership with patients and their caregivers. This will be the first study, internationally, to evaluate the clinical and cost effectiveness of Comprehensive Geriatric Assessment (CGA), a highly promising intervention for improving patient-important health outcomes in frail older people with Chronic Kidney Disease (CKD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 3, 2020
Enrollment StartMar 15, 2021
Primary CompletionJun 30, 2024
Study CompletionNov 19, 2024
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 5.8 years ago

Interventions

Comprehensive Geriatric Assessmentother

A CGA is a diagnostic and therapeutic intervention which initially identifies an older person's medical, functional, psychosocial problems and then tailors coordinated management plans to address them.